Last reviewed · How we verify
NCT06724068
Diabetes, Insulin Resistance and Body Composition
trial testing Diabetes，Insulin resistance，Control in Insulin Resistance, Diabetes in 515 participants. Completed in 31 August 2022.
31 August 2022
Quick facts
| Lead sponsor | Xuan Song |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 515 |
| Start date | 17 December 2021 |
| Primary completion | 31 August 2022 |
| Estimated completion | 31 August 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- Diabetes，Insulin resistance，Control
Conditions studied
- Insulin Resistance, Diabetes — all drugs for Insulin Resistance, Diabetes →
Sponsor
Xuan Song
Who can join
Adults 18 to 80, any sex, with Insulin Resistance, Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this retrospective study is to learn about the correlation between diabetes, insulin resistance and body compositions. The main question\[s\] it aims to answer are: * \[The difference of body composition between the individuals of insulin resistance and diabetes\] * \[The effect of diabetes on body composition\]
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06724068
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Insulin Resistance, Diabetes
Currently open trials in the same condition.
- NCT06400082 — Topical Insulin for Postoperative Wound Healing · NA · active not recruiting
- NCT06542718 — Studying Phenotypes of Gestational Diabetes Mellitus in an Asian Pregnant Cohort · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06724068 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xuan Song
- Last refreshed: 12 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06724068.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing